Priming knowledge in liver
cancer across disciplines
-
B-catenin activation and resistance to anti PD1 treatments in hepatocellular carcinoma
Cancer Discovery, August 2019 -
Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes
Nature Cell Biology, 22 July 2019 -
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study
Lancet Gastroenterology & Hepatology -
Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study
Journal of Clinical Oncology, 8 July 2019 -
Hepatocellular carcinoma xenografts established from needle biopsies preserve the characteristics of the originating tumors
Hepatology Communications, July 2019
The International Liver Cancer Association (ILCA) is the only international organisation devoted exclusively to liver cancer research for experts from all related disciplines.
Our mission is to lead a global Community of physicians, scientists and allied professionals through education and research with the goal to better prevent and treat liver cancer.
We will do so by promoting novel pathogenic, diagnostic and therapeutic interventions for liver cancer by taking a transversal approach to research and bringing together scientists, physicians and allied professionals from all interrelated fields.